Showing results (181-190 of 208) with videos related to
Sort By:
Pageof 21
Neurology|March 1, 1988
Clinical and neuropathologic assessment of severity in Huntington's diseaseR H Myers, J P Vonsattel, T J Stevens, et al.Neurochemical Pathology|June 1, 1986
Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brainP R Dodd, J A Hardy, E B Baig, et al.Brain Research|June 26, 1989
Uptake of gamma-aminobutyric acid and L-glutamic acid by synaptosomes from postmortem human cerebral cortex: multiple sites, sodium dependence and effect of tissue preparationP R Dodd, W E Watson, M M Morrison, et al.European Journal of Pharmacology|April 29, 1992
L-687,306: a functionally selective and potent muscarinic M1 receptor agonistS B Freedman, S Patel, E A Harley, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseasesP Seeman, N H Bzowej, H C Guan, et al.Neurology|October 16, 1999
Evidence for the GluR6 gene associated with younger onset age of Huntington's diseaseM E MacDonald, J P Vonsattel, J Shrinidhi, et al.Annals of Neurology|May 1, 1997
Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal gangliaS E Browne, A C Bowling, U MacGarvey, et al.Archives of Neurology|August 1, 1991
Factors associated with slow progression in Huntington's diseaseR H Myers, D S Sax, W J Koroshetz, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Lack of cholinergic deficit in the neocortex in Pick's diseaseP L Wood, N P Nair, P Etienne, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1985
Late onset of Huntington's diseaseR H Myers, D S Sax, M Schoenfeld, et al.Pageof 21